The use of continuous insulin delivery systems in severely insulin-resistant patients.

Diabetes care

Volumn 24, Issue 7, 2001, Pages 1299-

  Wainstein, J ^a   Metzger, M ^a   Wexler, I D ^a   Cohen, J ^a   Raz, I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

BLOOD; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN INFUSION; INSULIN RESISTANCE; LETTER; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; TIME; WEIGHT GAIN;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; MIDDLE AGED; TIME FACTORS; WEIGHT GAIN;

EID: 0035408217     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1299     Document Type: Letter

References (0)